OBLN Stock Price, Chart, Stats & News

Obalon Therapeutics, Inc.
Save
5.47M
Market cap
–
Current P/E
–
Forward P/E
OBLN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 68.43% |
Operating margin | -3237.78% |
Pretax margin | -3277.21% |
Net margin | -2897.28% |
Effective tax rate | -0.21% |
ROA | -142.57% |
ROE | -277.53% |
D/E | 0.01x |
Interest coverage ratio | -61.39x |
OBLN valuation
P/E | – |
P/S | 17.12x |
P/B | 0.95x |
P/CF | -0.44x |
P/FCF | -0.68x |
P/OCF | -0.44x |
PEG | -0.00x |
EV multiple | -1.01x |
About
Obalon Therapeutics, Inc. operates as a fully integrated medical device enterprise, concentrating its efforts on creating and commercializing innovative solutions for individuals battling obesity. The company's flagship offering is the Obalon Balloon System, specifically engineered to promote weight reduction in obese patients. This comprehensive system incorporates an ingestible capsule that houses an inflatable balloon connected to a microcatheter.
Similar securities
Based on sector and market capitalization
Report issue











